Nivolumab plus ipilimumab for localised kidney cancer By Sharon Deveson Kell|2022-08-22T14:51:07+00:0022 Aug 2022|Drug treatments| In a recent phase 3 clinical trial the combination of [...] Read More Comments Off on Nivolumab plus ipilimumab for localised kidney cancer